Table 3 Baseline demographics and clinical characteristics of study participants stratified by clinical category
Characteristic | All (n = 359) | Mild (n = 96) | Moderate (n = 171) | Severe (n = 92) | p value |
|---|---|---|---|---|---|
Age, mean ± SD | 45 ± 16.9 | 30.7 ± 14.2 | 48.6 ± 15.2 | 53.5 ± 13.1 | 0.000 |
Gender | 0.045 | ||||
Male | 180 (50.1) | 39 (40.6) | 87 (50.9) | 54 (58.7) | |
Female | 179 (49.9) | 57 (59.4) | 84 (49.1) | 38 (41.3) | |
Symptoms | |||||
Fever | 273 (76) | 41 (42.7) | 142 (83.0) | 90 (97.8) | 0.000 |
Cough | 259 (72.1) | 37 (38.5) | 135 (78.9) | 87 (94.5) | 0.000 |
DOB | 202 (56.3) | 0 (0) | 123 (71.9) | 79 (85.9) | 0.000 |
Diarrhea | 20 (5.6) | 5 (5.2) | 8 (4.6) | 7 (7.6) | 0.512 |
Comorbidities | 63 (17.5) | 10 (10.4) | 25 (14.6) | 28 (30.4) | 0.001 |
Hypertension | 24 (6.7) | 5 (5.2) | 10 (5.8) | 9 (9.8) | 0.379 |
Diabetes | 15 (4.2) | 2 (2.1) | 5 (2.9) | 8 (8.7) | 0.041 |
COPD | 11 (3.1) | 1 (1.0) | 4 (2.3) | 6 (6.5) | 0.070 |
Heart disease | 9 (2.5) | 2 (2.1) | 6 (3.5) | 1 (1.1) | 0.456 |
CKD | 4 (1.1) | 0 (0) | 0 (0) | 4 (4.3) | 0.004 |
Death | 22 (6.1) | 0 (0) | 0 (0) | 22 (23.7) | 0.000 |